ID
31895
Description
This ODM-file contains a form to document the vital signs. To be assessed at Day -1 of Period 1 and 2. Study ID: 106396 Clinical Study ID: TRX106396 Study Title: An open-label, randomized, single-dose, 2-period crossover study to evaluate sumatriptan pharmacokinetics for a TREXIMA™(sumatriptan 85mg and naproxen sodium 500mg)*, Tablet compared with an IMITREX® (sumatriptan) 100mg Tablet Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders Sponsor: GlaxoSmithKline
Keywords
Versions (2)
- 10/3/18 10/3/18 -
- 10/7/18 10/7/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 7, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Sumatriptan pharmacokinetics TREXIMA and IMITREX tablet 106396
Vital Signs Day -1 of Period 1 and 2
- StudyEvent: ODM
Description
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
Date of the measurement of the vital signs
Data type
date
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C0011008
Description
Time of the measurement of the vital signs
Data type
time
Alias
- UMLS CUI [1]
- C2826762
Description
Sitting
Data type
text
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0005823
Description
Heart rate
Data type
text
Measurement units
- beats/minute
Alias
- UMLS CUI [1]
- C0018810
Similar models
Vital Signs Day -1 of Period 1 and 2
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])